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Background: An avian-origin H7N9 virus emerged in eastern China in February 2013 and has since 
caused 133 confirmed human infections (Gao R, et al. N Engl J Med. 2013;368:1888-1897). We have 
compared human isolates and avian viruses isolated from epidemiologically linked poultry markets 
and confirmed that the human infections were caused by direct transmission from a poultry source 
(Chen Y, et al. Lancet. 2013;381:1916-1985). In addition to the Q226L substitution in the HA, which 
may provide virus with some ability to bind to human-type receptors, what other adaptations has this 
virus gained to make it different from other avian influenza viruses? Materials and Methods: We 
characterized H7N9 and other related H7 and N9 subtype viruses isolated in April 2013 from local 
poultry markets that were associated with human infections. Genetic mutations, polymerases activity, 
growth kinetic in mammalian and avian cells and replication ability in mice were determined using 
reverse genetic versions of H7N9 virus. Results: Replication ability and growth kinetics of the avian 
H7 subtype influenza viruses were compared in avian and mammalian cell lines. Our data suggest 
that the reassortant H7N9 virus has adapted to, and may have become established in, land-based 
poultry. It is currently not clear if this virus may still be circulating in some poultry populations, 
continuing to evolve and posing a threat for further human infections. We studied the virus genome for 
mammalian adaptation markers by performing sequence analysis on virus isolates and RT-PCR 
products derived from samples obtained from 46 patients hospitalized in the First Affiliated Hospital of 
Zhejiang University Medical School, Hangzhou, China. Virus adaptation markers in the HA, NA and 
PB2 genes were analyzed in sequential samples. Multiple adaptation markers were identified in these 
genes of clinical isolates and serial respiratory samples. Our data showed that the avian-origin H7N9 
has attempted to adapt to replicate in human cells using various mechanisms already displayed by 
other viruses. An in vitro assay showed that viruses with substitutions at these positions exhibit 
enhanced RNP polymerase activity, and a study of growth kinetics demonstrated that isolates carrying 
these adaptation markers replicate to a higher titer in mammalian cells. Replication efficiency of these 
clinical variants was also evaluated in mice. As neuraminidase inhibitors are used as the first line of 
antiviral drugs for the treatment of H7N9 infection, we also analyzed oseltamivir resistance-associated 
mutations in the NA genes of viruses shed in either serial nasal swab or sputum specimens obtained 
from 40 of the hospitalized patients. Conclusions: This study provides a comprehensive analysis of 
avian-origin H7N9 virus from poultry and in human infections. The novel H7N9 virus attempted 
multiple adaptive strategies for efficient replication in humans. Further characterization of this H7N9 
avian influenza virus for understanding the mechanism of replication adaptation and the role in 
efficient human transmission is necessary.   
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